NEWS

Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines 12/12/2024
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery 12/10/2024
Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect
Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect 12/04/2024
Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform
Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform 11/22/2024
UCSF Joins I-Corps’ New Regional Innovation Hub for the Northwest
UCSF Joins I-Corps’ New Regional Innovation Hub for the Northwest 11/19/2024
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections 11/13/2024
Enlaza Therapeutics marries covalent and biologic drugs
Enlaza Therapeutics marries covalent and biologic drugs 11/12/2024
Female Founders Social Event
Female Founders Social Event 11/07/2024
Minutia: Shifting the T1D Paradigm
Minutia: Shifting the T1D Paradigm 10/29/2024
BeeKeeperAI and Topcon Team Up to Accelerate Healthcare from the Eye
BeeKeeperAI and Topcon Team Up to Accelerate Healthcare from the Eye 10/11/2024
Neuvivo Seeks FDA Approval for Its Breakthrough ALS Treatment
Neuvivo Seeks FDA Approval for Its Breakthrough ALS Treatment 10/09/2024
Cardiology Panel Focused on the University’s Expertise
Cardiology Panel Focused on the University’s Expertise 10/03/2024
PreludeDx Announces Groundbreaking Study Results on HER2-Positive DCIS Patients
PreludeDx Announces Groundbreaking Study Results on HER2-Positive DCIS Patients 10/03/2024
Nexilico and Siolta Therapeutics Enter Collaboration Agreement to Develop a Novel Microbiome Therapeutic for Necrotizing Enterocolitis
Nexilico and Siolta Therapeutics Enter Collaboration Agreement to Develop a Novel Microbiome Therapeutic for Necrotizing Enterocolitis 09/18/2024
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate 09/12/2024